Vault-13

SEELOS THERAPEUTICS INC SEELQ

COM NEW · Common Stock · CUSIP 81577F406

0 institutional holders -2 vs Q4 2024
—reported value*
0 new 0 added 0 reduced 2 sold out net sold ≈ $4.8k (-20.6k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q1 2025

Institutional holders

Managers reporting a position, each quarter

01020Q3 24: 16Q4 24: 2Q1 25: 00Q3 24Q4 24Q1 25
Numbers
QuarterHolders
Q3 202416
Q4 20242
Q1 20250

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
20020Q4 24: 1 bought or addedQ4 24: 13 cut or sold outQ4 24Q1 25: 0 bought or addedQ1 25: 2 cut or sold outQ1 25
Numbers
QuarterBought or addedCut or sold out
Q4 2024113
Q1 202502

Biggest buyers

None

Biggest sellers

AdvisorShares Investments LLC Sold out -20,543-20.5k
Vermillion & White Wealth Management Group, LLC Sold out -7-7

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Weber Mark 13G · institution new · filed 2024-11-25 10.7% new 46.5k 2024-11-25
JANE STREET GROUP, LLC 13G · institution new · filed 2025-02-14 6.6% new 38.3k 2025-02-14

Holders, Q1 2025

#ManagerLocationShares Value% of their portfolioChangeShares change